WHO-World Health Organisation’s approval for India’s home-grown coronavirus vaccine is pending. Bharat Biotech, Covaxin,can take few more weeks. This is because WHO has raised some more questions on Covaxin. Bharat Biotech send the queries for further clarification.
A set of technical queries have been sent by the international health watchdog. A ource in the WHO said that it’s a routine process and there’s no concern in the matter. “It’s the usual process. Experts raise queries, which need to be answered by the company,” the source said.
Meanwhile Asked if the fresh set of queries will delay the approval further, the WHO source clarified that it may not cause much delay. “No, it should not be delayed… Maybe a few weeks,” the official said.
Meanwhile Bharat Biotech, last week, had again announced that the company has submitted all the relevant data. Also they submitted it to the WHO for emergency use listing (EUL) of Covaxin and is now awaiting feedback.
India’s vaccine scenario
Also So far, government administered over 9.28 crore doses of Covaxin have been .Meanwhile Bharat Biotech had submitted all the necessary documents required for the EUL on July 9. “All documents required for EUL of Covaxin have been submitted to WHO as of July 9. Also The review process has now commenced hoping that we will receive EUL from WHO at the earliest,” Dr Krishna Ella, chairman and managing director of Bharat Biotech, had said in a statement.
Meanwhile they released the statement in July. It was days after Suchitra Ella, said that the approval from the world health body won’t be a “long-drawn process”.
“We are working closely with the World Health Organisation for the inclusion of Covaxin in its Emergency Use Listing. Approval from WHO is not expected to be a long-drawn process . This is as the cell line and majority of our facilities have already been audited and approved by WHO for our other vaccines in the past,” Suchitra Ella had tweeted. Image credits: unsplashhttps://unsplash.com/photos/9vnACvX2748